Lessening the impact of cancer-causing hormones

February 9, 2012, Flinders University
Professor Peter Mackenzie

Increasing the production of proteins that help rid the body of toxins may play a crucial role in the fight against breast and prostate cancer, researchers from Flinders University believe.

Professor Peter Mackenzie (pictured), a Senior Principal Research Fellow in the School of Medicine, is leading a novel study that aims to boost the body’s supply of UGT enzymes – a family of proteins that eliminate fat soluble chemicals from the body by making them water soluble so they become less toxic and pass through the kidneys more readily.

Fat soluble chemicals include many therapeutic drugs, vitamins, environmental pollutants and the two steroid hormones oestrogen and testosterone.

While most fat soluble chemicals are not directly harmful, their levels need to be controlled as they can accumulate in the body to toxic levels.

As oestrogen and testosterone are known to stimulate the growth of breast and prostate cancers, their removal by UGT enzymes may help reduce cancer growth.

Professor Mackenzie said his research will analyse the properties of five specific enzymes responsible for metabolising oestrogen and testosterone to see how they can be maximised in cancer cells to lower hormone levels.

By increasing the amount of enzymes, Professor Mackenzie said it is hoped that levels in cancer cells can be reduced, thereby preventing or delaying the spread of disease.

“The initial stages of breast cancer are driven by oestrogen – once a cell changes to become a cancer, oestrogen contributes to its growth and it’s the same with , its growth is fuelled by abnormal androgen action,” Professor Mackenzie said.

“So if we can find a way to maximise the amount of enzymes made in these cells it might help reduce growth driven by oestrogen or testosterone because without this growth, hormone-dependent cancers such as breast and prostate cancer can’t survive,” he said.

“Unfortunately it will take some time to understand the underlying mechanisms, and then the next battle will be to find a drug that can increase the enzymes without being toxic or affecting the growth of the cell in a positive way.”

The three-year study will also investigate how therapeutic drugs can be used more effectively “so when they’ve carried out what they’re supposed to do, they leave the body and don’t accumulate to toxic levels”, Professor Mackenzie said.

Explore further: Reprogrammed oestrogen binding linked to more aggressive breast cancer

Related Stories

Reprogrammed oestrogen binding linked to more aggressive breast cancer

January 4, 2012
(Medical Xpress) -- Scientists based at Cancer Research UK’s Cambridge Research Institute have discovered how receptors for the female sex hormone oestrogen attach to a different part of the DNA in breast cancer patients ...

Elevated hormone levels add up to increased breast cancer risk

October 21, 2011
Post-menopausal women with high levels of hormones such as estrogen or testosterone are known to have a higher risk of breast cancer. New research published in BioMed Central's open access journal Breast Cancer Research looked ...

Scientists find new drug target in breast cancer

May 22, 2011
Researchers have identified a new protein involved in the development of drug resistance in breast cancer which could be a target for new treatments, they report today in the journal Nature Medicine.

New hope for advanced post-menopausal breast cancer patients resistant to hormonal therapy

September 26, 2011
Results from a phase III clinical trial have shown that combining two existing cancer drugs to treat post-menopausal women with advanced breast cancer resistant to hormonal therapy significantly improves outcome. Researchers ...

Recommended for you

Boosting cancer therapy with cross-dressed immune cells

January 22, 2018
Researchers at EPFL have created artificial molecules that can help the immune system to recognize and attack cancer tumors. The study is published in Nature Methods.

Workouts may boost life span after breast cancer

January 22, 2018
(HealthDay)—Longer survival after breast cancer may be as simple as staying fit, new research shows.

Cancer patients who tell their life story find more peace, less depression

January 22, 2018
Fifteen years ago, University of Wisconsin–Madison researcher Meg Wise began interviewing cancer patients nearing the end of life about how they were living with their diagnosis. She was surprised to find that many asked ...

Single blood test screens for eight cancer types

January 18, 2018
Johns Hopkins Kimmel Cancer Center researchers developed a single blood test that screens for eight common cancer types and helps identify the location of the cancer.

Researchers find a way to 'starve' cancer

January 18, 2018
Researchers at Vanderbilt University Medical Center (VUMC) have demonstrated for the first time that it is possible to starve a tumor and stop its growth with a newly discovered small compound that blocks uptake of the vital ...

How cancer metastasis happens: Researchers reveal a key mechanism

January 18, 2018
Cancer metastasis, the migration of cells from a primary tumor to form distant tumors in the body, can be triggered by a chronic leakage of DNA within tumor cells, according to a team led by Weill Cornell Medicine and Memorial ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.